Aquestive Therapeutics, Inc. — All Filings
618 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001398733-26-000020 | Mar 20, 2026 | Mar 16, 2026 |
| 4 | PRIMARY DOCUMENT | 0001214659-26-003147 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | PRIMARY DOCUMENT | 0001214659-26-003146 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | PRIMARY DOCUMENT | 0001214659-26-003145 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | PRIMARY DOCUMENT | 0001214659-26-003144 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | PRIMARY DOCUMENT | 0001214659-26-003143 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | PRIMARY DOCUMENT | 0001214659-26-003142 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | PRIMARY DOCUMENT | 0001214659-26-003141 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | PRIMARY DOCUMENT | 0001214659-26-003140 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | PRIMARY DOCUMENT | 0001214659-26-003134 | Mar 11, 2026 | Mar 9, 2026 |
| 3 | PRIMARY DOCUMENT | 0001214659-26-003133 | Mar 11, 2026 | Mar 2, 2026 |
| S-8 | — | 0001214659-26-002827 | Mar 4, 2026 | — |
| 10-K | 10-K | 0001398733-26-000018 | Mar 4, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001398733-26-000016 | Mar 4, 2026 | Mar 3, 2026 |
| 8-K | 8-K | 0001398733-26-000007 | Feb 26, 2026 | — |
| 8-K | 8-K | 0001398733-26-000005 | Feb 2, 2026 | Jan 30, 2026 |
| S-8 | — | 0001214659-26-000711 | Jan 21, 2026 | — |
| 8-K | 8-K | 0001398733-26-000003 | Jan 9, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0001214659-25-017652 | Dec 5, 2025 | Dec 4, 2025 |
| 4 | PRIMARY DOCUMENT | 0001214659-25-017591 | Dec 4, 2025 | Dec 2, 2025 |
| 144 | — | 0001968582-25-001073 | Nov 17, 2025 | — |
| SCHEDULE 13G | — | 0001493215-25-000037 | Nov 14, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001214659-25-016275 | Nov 12, 2025 | Nov 10, 2025 |
| 3 | PRIMARY DOCUMENT | 0001214659-25-016274 | Nov 12, 2025 | Nov 3, 2025 |
| 8-K | 8-K | 0001398733-25-000030 | Nov 6, 2025 | — |
| 10-Q | 10-Q | 0001398733-25-000028 | Nov 5, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001398733-25-000027 | Nov 5, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001214659-25-015048 | Oct 17, 2025 | Oct 15, 2025 |
| 4 | PRIMARY DOCUMENT | 0001214659-25-015047 | Oct 17, 2025 | Oct 15, 2025 |
| 4 | PRIMARY DOCUMENT | 0001214659-25-015046 | Oct 17, 2025 | Oct 15, 2025 |
| SCHEDULE 13G/A | — | 0002012383-25-002498 | Oct 17, 2025 | — |
| 144 | — | 0001968582-25-000998 | Oct 15, 2025 | — |
| 144 | — | 0001950047-25-007999 | Oct 15, 2025 | — |
| 144 | — | 0001628280-25-045063 | Oct 15, 2025 | — |
| 8-K | 8-K | 0001398733-25-000022 | Oct 8, 2025 | — |
| 8-K | 8-K | 0001398733-25-000020 | Oct 1, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001214659-25-014288 | Sep 29, 2025 | Sep 26, 2025 |
| 4 | PRIMARY DOCUMENT | 0001214659-25-014287 | Sep 29, 2025 | Sep 26, 2025 |
| 144 | — | 0001628280-25-043082 | Sep 29, 2025 | — |
| 144 | — | 0001950047-25-007535 | Sep 26, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001214659-25-014009 | Sep 22, 2025 | Sep 19, 2025 |
| 144 | — | 0001950047-25-007378 | Sep 19, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001214659-25-013493 | Sep 8, 2025 | Sep 4, 2025 |
| 4 | PRIMARY DOCUMENT | 0001214659-25-013485 | Sep 8, 2025 | Sep 5, 2025 |
| 8-K | 8-K | 0001398733-25-000018 | Sep 8, 2025 | — |
| 144 | — | 0002007317-25-001032 | Sep 5, 2025 | — |
| 144 | — | 0001950047-25-006754 | Sep 4, 2025 | — |
| 8-K | 8-K | 0001398733-25-000016 | Sep 4, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001214659-25-012304 | Aug 15, 2025 | Aug 14, 2025 |
| 8-K | 8-K | 0001140361-25-031374 | Aug 15, 2025 | Aug 14, 2025 |